Logo image of ZIMV

ZIMVIE INC (ZIMV) Stock Fundamental Analysis

USA - NASDAQ:ZIMV - US98888T1079 - Common Stock

18.99 USD
0 (0%)
Last: 10/17/2025, 8:00:02 PM
19 USD
+0.01 (+0.05%)
After Hours: 10/17/2025, 8:00:02 PM
Fundamental Rating

4

Taking everything into account, ZIMV scores 4 out of 10 in our fundamental rating. ZIMV was compared to 189 industry peers in the Health Care Equipment & Supplies industry. ZIMV has only an average score on both its financial health and profitability. ZIMV is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ZIMV was profitable.
In the past year ZIMV had a positive cash flow from operations.
In the past 5 years ZIMV always reported negative net income.
In the past 5 years ZIMV always reported a positive cash flow from operatings.
ZIMV Yearly Net Income VS EBIT VS OCF VS FCFZIMV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M

1.2 Ratios

ZIMV has a better Return On Assets (-2.57%) than 67.89% of its industry peers.
Looking at the Return On Equity, with a value of -4.72%, ZIMV is in the better half of the industry, outperforming 68.42% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 0.77%, ZIMV is in the better half of the industry, outperforming 66.84% of the companies in the same industry.
Industry RankSector Rank
ROA -2.57%
ROE -4.72%
ROIC 0.77%
ROA(3y)-13.32%
ROA(5y)-10.87%
ROE(3y)-37.08%
ROE(5y)-25.96%
ROIC(3y)N/A
ROIC(5y)N/A
ZIMV Yearly ROA, ROE, ROICZIMV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

The Operating Margin of ZIMV (1.42%) is better than 66.32% of its industry peers.
The Gross Margin of ZIMV (65.31%) is better than 70.00% of its industry peers.
In the last couple of years the Gross Margin of ZIMV has remained more or less at the same level.
Industry RankSector Rank
OM 1.42%
PM (TTM) N/A
GM 65.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.03%
GM growth 5Y-1.34%
ZIMV Yearly Profit, Operating, Gross MarginsZIMV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ZIMV is destroying value.
The number of shares outstanding for ZIMV has been increased compared to 1 year ago.
The number of shares outstanding for ZIMV has been increased compared to 5 years ago.
Compared to 1 year ago, ZIMV has an improved debt to assets ratio.
ZIMV Yearly Shares OutstandingZIMV Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ZIMV Yearly Total Debt VS Total AssetsZIMV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

ZIMV has an Altman-Z score of 0.91. This is a bad value and indicates that ZIMV is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.91, ZIMV perfoms like the industry average, outperforming 49.47% of the companies in the same industry.
ZIMV has a debt to FCF ratio of 39.31. This is a negative value and a sign of low solvency as ZIMV would need 39.31 years to pay back of all of its debts.
ZIMV's Debt to FCF ratio of 39.31 is fine compared to the rest of the industry. ZIMV outperforms 67.89% of its industry peers.
ZIMV has a Debt/Equity ratio of 0.53. This is a neutral value indicating ZIMV is somewhat dependend on debt financing.
ZIMV's Debt to Equity ratio of 0.53 is on the low side compared to the rest of the industry. ZIMV is outperformed by 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 39.31
Altman-Z 0.91
ROIC/WACC0.11
WACC7.06%
ZIMV Yearly LT Debt VS Equity VS FCFZIMV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

ZIMV has a Current Ratio of 2.37. This indicates that ZIMV is financially healthy and has no problem in meeting its short term obligations.
ZIMV's Current ratio of 2.37 is in line compared to the rest of the industry. ZIMV outperforms 45.79% of its industry peers.
A Quick Ratio of 1.60 indicates that ZIMV should not have too much problems paying its short term obligations.
ZIMV's Quick ratio of 1.60 is in line compared to the rest of the industry. ZIMV outperforms 43.16% of its industry peers.
Industry RankSector Rank
Current Ratio 2.37
Quick Ratio 1.6
ZIMV Yearly Current Assets VS Current LiabilitesZIMV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 135.90% over the past year.
Looking at the last year, ZIMV shows a very negative growth in Revenue. The Revenue has decreased by -50.48% in the last year.
Measured over the past years, ZIMV shows a very negative growth in Revenue. The Revenue has been decreasing by -15.69% on average per year.
EPS 1Y (TTM)135.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-50.48%
Revenue growth 3Y-23.75%
Revenue growth 5Y-15.69%
Sales Q2Q%13.02%

3.2 Future

The Earnings Per Share is expected to grow by 19.35% on average over the next years. This is quite good.
ZIMV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.42% yearly.
EPS Next Y54.53%
EPS Next 2Y25.74%
EPS Next 3Y19.35%
EPS Next 5YN/A
Revenue Next Year0.03%
Revenue Next 2Y0.64%
Revenue Next 3Y0.42%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ZIMV Yearly Revenue VS EstimatesZIMV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
ZIMV Yearly EPS VS EstimatesZIMV Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 20.64, the valuation of ZIMV can be described as rather expensive.
Based on the Price/Earnings ratio, ZIMV is valued a bit cheaper than 80.00% of the companies in the same industry.
ZIMV's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.91.
With a Price/Forward Earnings ratio of 20.02, ZIMV is valued on the expensive side.
Based on the Price/Forward Earnings ratio, ZIMV is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
ZIMV's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 34.57.
Industry RankSector Rank
PE 20.64
Fwd PE 20.02
ZIMV Price Earnings VS Forward Price EarningsZIMV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ZIMV is valued a bit cheaper than 78.42% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ZIMV is valued a bit cheaper than 70.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 95.36
EV/EBITDA 16.74
ZIMV Per share dataZIMV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

ZIMV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ZIMV's earnings are expected to grow with 19.35% in the coming years.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y25.74%
EPS Next 3Y19.35%

0

5. Dividend

5.1 Amount

No dividends for ZIMV!.
Industry RankSector Rank
Dividend Yield N/A

ZIMVIE INC

NASDAQ:ZIMV (10/17/2025, 8:00:02 PM)

After market: 19 +0.01 (+0.05%)

18.99

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)10-29 2025-10-29/amc
Inst Owners90.35%
Inst Owner Change2.73%
Ins Owners2.73%
Ins Owner Change-1640.78%
Market Cap535.52M
Revenue(TTM)443.40M
Net Income(TTM)-19.47M
Analysts48.89
Price Target16.32 (-14.06%)
Short Float %2.47%
Short Ratio1.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.01%
Min EPS beat(2)21.96%
Max EPS beat(2)26.05%
EPS beat(4)4
Avg EPS beat(4)32.05%
Min EPS beat(4)1.94%
Max EPS beat(4)78.25%
EPS beat(8)6
Avg EPS beat(8)107.43%
EPS beat(12)9
Avg EPS beat(12)152.03%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.92%
Min Revenue beat(2)-3.18%
Max Revenue beat(2)1.35%
Revenue beat(4)1
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-3.62%
Max Revenue beat(4)1.35%
Revenue beat(8)2
Avg Revenue beat(8)-2.36%
Revenue beat(12)4
Avg Revenue beat(12)-1.34%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)37.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.5%
EPS NY rev (1m)0%
EPS NY rev (3m)7.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.52%
Valuation
Industry RankSector Rank
PE 20.64
Fwd PE 20.02
P/S 1.21
P/FCF 95.36
P/OCF 44.75
P/B 1.3
P/tB 8.91
EV/EBITDA 16.74
EPS(TTM)0.92
EY4.84%
EPS(NY)0.95
Fwd EY5%
FCF(TTM)0.2
FCFY1.05%
OCF(TTM)0.42
OCFY2.23%
SpS15.72
BVpS14.64
TBVpS2.13
PEG (NY)0.38
PEG (5Y)N/A
Graham Number17.41
Profitability
Industry RankSector Rank
ROA -2.57%
ROE -4.72%
ROCE 0.97%
ROIC 0.77%
ROICexc 0.86%
ROICexgc 2.21%
OM 1.42%
PM (TTM) N/A
GM 65.31%
FCFM 1.27%
ROA(3y)-13.32%
ROA(5y)-10.87%
ROE(3y)-37.08%
ROE(5y)-25.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.03%
GM growth 5Y-1.34%
F-Score6
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 39.31
Debt/EBITDA 5.39
Cap/Depr 18.32%
Cap/Sales 1.43%
Interest Coverage 0.43
Cash Conversion 29.2%
Profit Quality N/A
Current Ratio 2.37
Quick Ratio 1.6
Altman-Z 0.91
F-Score6
WACC7.06%
ROIC/WACC0.11
Cap/Depr(3y)17.11%
Cap/Depr(5y)24.69%
Cap/Sales(3y)2.37%
Cap/Sales(5y)3.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)135.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y54.53%
EPS Next 2Y25.74%
EPS Next 3Y19.35%
EPS Next 5YN/A
Revenue 1Y (TTM)-50.48%
Revenue growth 3Y-23.75%
Revenue growth 5Y-15.69%
Sales Q2Q%13.02%
Revenue Next Year0.03%
Revenue Next 2Y0.64%
Revenue Next 3Y0.42%
Revenue Next 5YN/A
EBIT growth 1Y126.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year148.72%
EBIT Next 3Y45.39%
EBIT Next 5YN/A
FCF growth 1Y117.33%
FCF growth 3Y-0.91%
FCF growth 5Y-35.32%
OCF growth 1Y192.13%
OCF growth 3Y-39.59%
OCF growth 5Y-34.68%

ZIMVIE INC / ZIMV FAQ

Can you provide the ChartMill fundamental rating for ZIMVIE INC?

ChartMill assigns a fundamental rating of 4 / 10 to ZIMV.


Can you provide the valuation status for ZIMVIE INC?

ChartMill assigns a valuation rating of 5 / 10 to ZIMVIE INC (ZIMV). This can be considered as Fairly Valued.


What is the profitability of ZIMV stock?

ZIMVIE INC (ZIMV) has a profitability rating of 4 / 10.


What is the valuation of ZIMVIE INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ZIMVIE INC (ZIMV) is 20.64 and the Price/Book (PB) ratio is 1.3.


Can you provide the dividend sustainability for ZIMV stock?

The dividend rating of ZIMVIE INC (ZIMV) is 0 / 10 and the dividend payout ratio is 0%.